FDA UDI In Commercial Distribution 🇺🇸 United States

Allurion™ Gastric Balloon System

DI: 00810010540119 · Model: FS010-16-US · Allurion Technologies, Inc.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
Allurion™ Gastric Balloon System
Primary DI
00810010540119
Version / Model
FS010-16-US
Catalog Number
30
Company Name
Allurion Technologies, Inc.
Labeler DUNS
078355007
Distribution Status
In Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2026-04-07
Public Version
1
Public Version Date
2026-04-15
Public Version Status
New
Public Device Record Key
0cce27b5-0c5e-4eec-80a4-47b83032200f

Device Description

Approval for the Allurion Gastric Balloon System (AGBS) is indicated to promote short-term limited weight loss in adult individuals with obesity between the ages of 22 years and 65 years with a body mass index (BMI) greater than or equal to 30 kg/m2 and less than or equal to 40 kg/m2 who have had at least one unsuccessful attempt at a weight loss program. The residence time for each AGBS is variable with an average observed residence time of 15.3 weeks. The AGBS is to be used in conjunction with a moderate intensity lifestyle modification therapy program. The AGBS consists of up to two Allurion Balloons placed during a 10-month period.

Device Characteristics

Single Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
No
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
Yes
MRI Safety
MR Safe
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
No
Has Lot/Batch Number
Yes
Has Manufacturing Date
Yes
Has Expiration Date
Yes
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
LTI Implant, Intragastric For Morbid Obesity

GMDN Terms

Code Name
17202 Appetite-suppression gastric balloon

Identifiers

Type ID
Primary 00810010540119

Premarket Submissions

Submission Number Supplement Number
P250023 000